Lactulosa Level (Lactulose)

Lactulose reaches the colon unchanged, where gut bacteria break it down into short‑chain fatty acids. This creates an osmotic gradient that draws water into the intestinal lumen, softening stools, while the resulting acidic environment reduces ammonia absorption, benefiting patients with liver‑related encephalopathy.

The dose of lactulose is individualized by the prescribing clinician based on the patient’s condition, severity of constipation or hepatic encephalopathy, and response to therapy. Only a qualified health professional should determine the appropriate regimen.

Safety data for lactulose in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any possible risk to the fetus or infant, and the decision should be made by a healthcare provider after careful evaluation.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and necessary import documentation.

Lactulose is an osmotic laxative that works by increasing water content in the colon, unlike stimulant laxatives that trigger intestinal muscle contractions. It also has the added benefit of reducing ammonia absorption, a property not shared by most other laxatives, making it useful for hepatic encephalopathy.

Lactulosa Level should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the container tightly closed and out of reach of children.

Lactulosa Level is taken orally, usually as a liquid or tablet, as directed by a healthcare professional. It can be mixed with water or another suitable beverage if a liquid formulation is used, and should be swallowed with a full glass of fluid.

Serious risks include severe electrolyte disturbances such as hypokalemia, dehydration from excessive diarrhea, and rare allergic reactions. Patients with advanced liver disease should be monitored closely for any signs of worsening hepatic function.

Lactulose should be avoided in individuals with known hypersensitivity to lactulose or any component of the formulation, and it is generally contraindicated in patients with intestinal obstruction, perforation, or severe inflammatory bowel disease without medical supervision.